Akt is an endogenous inhibitor toward tumor necrosis factor-related apoptosis inducing ligand-mediated apoptosis in rheumatoid synovial cells

Biochemical and Biophysical Research Communications

Volumn 312, Issue 2, 2003, Pages 397-404

  Miyashita, Taiichiro ^a   Kawakami, Atsushi ^a   Tamai, Mami ^a   Izumi, Yasumori ^a   Mingguo, Huang ^a   Tanaka, Fumiko ^a   Abiru, Seigou ^a   Nakashima, Koto ^a   Iwanaga, Nozomi ^a   Aratake, Koichiro ^a   Kamachi, Makoto ^a   Arima, Kazuhiko ^a   Ida, Hiroaki ^a   Migita, Kiyoshi ^a   Origuchi, Tomoki ^a   Tagashira, Shuzo ^b   Nishikaku, Fumio ^b   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Akt; Apoptosis; Rheumatoid arthritis; Synovial cells; TRAIL

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; ISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; LEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; RECEPTOR; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 10744229698     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.141     Document Type: Article

References (25)

1. Vaishnaw A.K., McNally J.D., Elkon K.B. Apoptosis in the rheumatic diseases. Arthritis Rheum. 40:1997;1917-1927.
2. Kawakami A., Eguchi K. Involvement of apoptotic cell death in autoimmune diseases. Med. Electron. Microsc. 35:2002;1-8.
3. Watson M.L., Rao J.K., Gilkeson G.S., Ruiz P., Eicher E.M., Pisetsky D.S., et al. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1992;1645-1656.
4. Wu J., Zhou T., Zhang J., He J., Gause W.C., Mountz J.D. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA. 91:1994;2344-2348.
5. Hilliard B., Wilmen A., Seidel C., Liu T.-S.T., Göke R., Chen Y. Role of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J. Immunol. 166:2001;1314-1319.
6. Song K., Chen Y., Goke R., Wilmen A., Seidel C., Goke A., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J. Exp. Med. 191:2000;1095-1104.
7. Lamhamedi-Cherradi S.-E., Zheng S.-J., Maguschak K.A., Peschon J., Chen Y.H. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat. Immunol. 4:2003;255-260.
8. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., et al. The receptor for the cytotoxic ligand TRAIL. Science. 276:1997;111-113.
9. Pan G., Ni J., Wei Y.F., Yu G., Gentz R., Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 277:1997;815-818.
10. Yamasaki S., Kawakami A., Nakashima T., Nakamura H., Kamachi M., Honda S., et al. Importance of NF-kappaB in rheumatoid synovial tissues: in situ NF-kappaB expression and in vitro study using cultured synovial cells. Ann. Rheum. Dis. 60:2001;678-684.
11. Thakkar H., Chen X., Tyan F., Gim S., Robinson H., Lee C., et al. Pro-survival function of Akt/Protein kinase B in prostate cancer cells. J. Biol. Chem. 276:2001;38361-38369.
12. Chen X., Thakkar H., Tyan F., Gim S., Robinson H., Lee C., et al. Constitutive active Akt is an important of TRAIL sensitivity in prostate cancer. Oncogene. 20:2001;6073-6083.
13. Nesterov A., Lu X., Johnson M., Miller G.J., Ivashchenko Y., Kraft A.S. Elevated Akt activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J. Biol. Chem. 276:2001;10767-10774.
14. Gibson E.M., Henson E.S., Haney N., Villanueva J., Gibson S.B. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res. 62:2002;488-496.
15. Zhang H.-G., Wang Y., Xie J.F., Liang X., Liu D., Yang P., et al. Regulation of tumor necrosis factor. α -mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt Arthritis Rheum. 44:2001;1555-1567.
16. Shibatomi K., Ida H., Yamasaki S., Nakashima T., Origuchi T., Kawakami A., et al. A novel role of interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases. Arthritis Rheum. 44:2001;884-892.
17. Kamachi M., Kawakami A., Yamasaki S., Hida A., Nakashima T., Nakamura H., et al. Regulation of apoptotic cell death by cytokines in a human salivary gland cell line: distinct and synergistic mechanisms in apoptosis induced by tumor necrosis factor alpha and interferon gamma. J. Lab. Clin. Med. 139:2002;13-19.
18. Migita K., Honda S., Yamasaki S., Hirai Y., Fukuda T., Aoyagi T., et al. Regulation of rheumatoid synovial cell growth by ceramide. Biochem. Biophys. Res. Commun. 269:2000;70-75.
19. Söderström T.S., Poukkuka M., Holmström T.H., Heiskanen K.M., Eriksson J.E. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogated TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J. Immunol. 169:2002;2851-2860.
20. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature. 423:2003;356-361.
21. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
22. Ozoren N., El-Deiry W.S. Defining characteristics of type I and type II apoptotic cells in response to TRAIL. Neoplasia. 4:2002;551-557.
23. Soane L., Cho H.J., Niculescu F., Rus H., Shin M.L. C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway. J. Immunol. 167:2001;2305-2311.
24. Datta S.R., Ranger A.M., Lin M.Z., Sturgill J.F., Ma Y.C., Cowan C.W., et al. Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev. Cell. 3:2002;631-643.
25. Ichikawa K., Liu W., Fleck M., Zhang H., Zhao L., Ohtsuki T., et al. TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J. Immunol. 171:2003;1061-1069.